Anatomical Pathology Market: By Product & Services (Services (Histopathology and Cytopathology), Instruments (Slide Staining Systems (Tissue Processing Systems, Cell Processors, Microtomes, Embedded Systems, Coverslippers, and Others), Consumables (Antibodies, Primary Antibodies, and Secondary Antibodies), Kits & Reagents (Stains & Solvents, Fixatives, and Others), Probes, Other Consumables)), By Application (Disease Diagnosis, Drug Discovery and Development, and Others), End-use (Hospitals, Research Laboratories, Diagnostic Laboratories, and Others), and Geography

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Anatomical Pathology Market size was valued at USD 18,739.5 million in 2021 and is poised to grow at a significant CAGR of 8.3% over 2022–2028. The widespread use of modern pathology technology, such as staining systems, gross imaging, and digital microscopes, is expected to improve anatomic pathological techniques significantly. Digital imaging options outperform traditional procedures in terms of specificity and accuracy, increasing the market for anatomic pathology services. Furthermore, the industry is driven by various partnerships and agreement ventures among significant firms to introduce an effective portfolio. For example, in April 2021, Royal Philips partnered with Ibex Medical Analytics, a business specializing in AI-based cancer diagnoses, to promote AI-based digital pathology adoption. Both organizations merged their knowledge to provide pathologists with enhanced solutions. Also, in oncology drug trials, anatomic pathology products and services are utilized to assess quantitative data, discover morphological structures, detect pharmacodynamic markers, and better comprehend drug processes. It's also used to divide trial participants into groups depending on tissue reactions to medicines.Tissue diagnostics make trials and retrospective investigations more efficient by lowering the cost and time. The PD-L1 (programmed death-ligand 1) expression was measured using an experimental immunohistochemistry (IHC) test developed by Roche Tissue Diagnostics in a Phase III study for Roche's cancer immunotherapy, TECENTRIQ (atezolizumab). Furthermore, the instruments category is expected to develop due to ongoing technological advancements and targeted efforts by market competitors to produce anatomic pathological instruments with superior designs. For example, Precision Instruments released the CF-6100 cryostat in April 2020. This cryostat encourages and supports tissue sectioning in dermatology, histology, and pathology. Diagnostic laboratories have benefited from improved testing equipment and technology, which has offered significant expansion opportunities. Similarly, the expansion of the research laboratory sector has been aided by a high number of clinical studies carried out as part of numerous ongoing initiatives. With the overall goal of achieving a high level of patient satisfaction, the research laboratory is committed to providing timely and complete information regarding the function of sick tissues. Recent Market Developments: In May 2021, Hologic received premarket approval (PMA) from the FDA for its ThinPrep GenesisTM processor for cytology processing and specimen transfer for downstream applications. In May 2021, a digital pathology solutions provider-OptraSCAN introduced CytoSiA-an intelligent solution for affordable and rapid scanning and analysis of pap smears and liquid-based cytology slides. This instrument allows whole slide cytology imaging with advanced image analysis.

Anatomical Pathology Market Summary

Study Period


Base Year




Largest Market

Asia Pacific

Fastest Growing Market

North America
Anatomical Pathology Market Dynamics

As the necessity for diagnosing and treating tumor cases has grown alarming, the demand for anatomic pathology has surged globally. The number of cancer cases has increased dramatically over the previous few years, as has the number of cancer-related deaths. According to WHO, cancer is responsible for around 1 in every 6 deaths worldwide. 19.3 million new cancer cases were reported in 2020, with that number predicted to rise to 30.2 million by 2040. The rising elderly population and the overall population are to blame for the rise in cancer incidence. According to the World Population Ageing 2020 report, the worldwide population of 65 and more was 727 million in 2020 and is anticipated to quadruple to 1.5 billion by 2050. This demographic trend is predicted to result in a considerable increase in the prevalence of several chronic diseases, including cancer, worldwide because the elderly is more sensitive to various ailments. Result in, increasing demand for anatomical products and service in the market. The lack of reconditioned anatomic pathology instruments is a significant impediment to the market's expansion.

Key Features of the Reports

  • The anatomical pathology market report provides granular level information about the market size, regional market share, historic market (2017-2021), and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Anatomical Pathology Market Segmentation

By Product Type
  • Services
    • Histopathology
    • Cytopathology
  • Instruments
    • Slide Staining Systems
    • Tissue Processing Systems
    • Cell Processors
    • Microtomes
    • Embedded Systems
    • Coverslippers
    • Others
  • Consumables
  • Antibodies
    • Primary Antibodies
    • Secondary Antibodies
  • Kits & Reagents
    • Stains & Solvents
    • Fixatives
    • Others
  • Probes
  • Other Consumables
By Application
  • Disease Diagnosis
  • Drug Discovery
  • Development and Others
  • Hospitals
  • Research Laboratories
  • Diagnostic Laboratories
  • Others

Frequently Asked Questions

The anatomical pathology market is projected to expand at a CAGR of 8.3% during the forecast period

Hoffmann-La Roche AG, Agilent Technologies, Inc., Cardinal Health, Sakura Finetek USA, Inc., NeoGenomics Laboratories, Inc.

North America is the fastest-growing region for anatomical pathology market

  • Danaher Corporation
  • PHC Holdings Corporation
  • Quest Diagnostics Incorporated
  • Laboratory Corporation of America Holdings
  • Hoffmann-La Roche AG
  • Agilent Technologies, Inc.
  • Cardinal Health
  • Sakura Finetek USA, Inc.
  • NeoGenomics Laboratories, Inc.
  • BioGenex
  • Bio SB